SEC Company Filings
Chemomab Completes Merger with Anchiano Therapeutics (READ MORE) (March 16, 2021)
Contact:
Investor Relations: Irina Koffler, LifeSci Advisors, LLC
Phone: +1-917-734-7387
Email: ir@chemomab.com
Chemomab Therapeutics: Sharon Elkobi, VP, Business Development
Phone: +972773310156
Email: bd@chemomab.com
Visit Chemomab online at www.chemomab.com
Anchiano Therapeutics Ltd. CIK#: 0001534248 (link to EDGAR)
Filing Date Form (Link to docs.) Description Download
21-03-17 8-K Current report, items 1.01, 2.01, 3.02, 3.03, 5.01, 5.02, 5.03, 5.07, and 9.01 PDF
21-03-10 8-K Current report, item 8.01 PDF
21-03-10 425 Prospectuses and communications, business combinations PDF
21-03-09 10-K Annual report [Section 13 and 15(d), not S-K Item 405] PDF
21-03-09 425 Prospectuses and communications, business combinations PDF
21-02-12 424B3 Prospectus [Rule 424(b)(3)] PDF
21-02-10 EFFECT Notice of Effectiveness PDF
21-02-10 S-4/A Registration of securities, business combinations [Amend] PDF
21-02-08 8-K Current report, item 8.01 PDF
21-02-08 425 Prospectuses and communications, business combinations PDF
21-02-02 425 Prospectuses and communications, business combinations PDF
21-01-13 S-4 Registration of securities, business combinations PDF
21-01-11 425 Prospectuses and communications, business combinations PDF
21-01-05 425 Prospectuses and communications, business combinations PDF
20-12-15 8-K Current report, items 1.01, 8.01, and 9.01 PDF
20-12-15 DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material PDF
20-11-16 10-Q Quarterly report [Sections 13 or 15(d)] PDF
20-10-20 8-K Current report, item 5.02 PDF
20-08-14 10-Q Quarterly report [Sections 13 or 15(d)] PDF
20-07-15 8-K Current report, item 5.02 PDF
20-07-09 8-K Current report, items 5.02 and 8.01 PDF
20-05-21 8-K Current report, item 5.02 PDF
20-05-07 10-Q Quarterly report [Sections 13 or 15(d)] PDF
20-05-06 8-K Current report, items 5.02, 7.01, and 9.01 PDF
20-04-24 8-K Current report, item 5.07 PDF
20-04-17 DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material PDF
20-04-15 8-K Current report, item 3.01 PDF
20-03-30 Pre 14A Other preliminary proxy statements PDF
20-03-17 S-8 Securities to be offered to employees in employee benefit plans PDF
20-03-17 10-K Annual report [Section 13 and 15(d), not S-K Item 405] PDF
20-03-16 8-K Current report, item 8.01 PDF
20-02-10 8-K Current report, items 5.02 and 8.01 PDF
20-02-04 8-K Current report, items 2.05, 7.01, and 9.01 PDF
20-01-31 8-K Current report, item 8.01 PDF
20-01-10 8-K Current report, item 8.01 PDF
20-01-02 8-K Current report, items 5.02 and 8.01 PDF
19-11-21 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] PDF
19-11-15 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] PDF
19-11-12 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] PDF
19-10-28 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] PDF
19-09-23 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] PDF
19-08-13 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] PDF
19-08-06 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] PDF
19-07-22 S-8 Securities to be offered to employees in employee benefit plans PDF
19-07-08 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] PDF
19-06-18 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] PDF
19-05-28 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] PDF
19-05-22 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] PDF
19-04-24 20-F/A Annual and transition report of foreign private issuers [Sections 13 or 15(d)] [Amend] PDF
19-03-25 20-K Annual and transition report of foreign private issuers [Sections 13 or 15(d)] PDF
19-03-14 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] PDF
19-03-12 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] PDF
19-02-14 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] PDF
19-02-13 424B4 Prospectus [Rule 424(b)(4)] PDF
19-02-12 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] PDF
19-02-11 F-1/A Registration statement for certain foreign private issuers [Amend] PDF
19-02-08 8-A12B Registration of securities [Section 12(b)] PDF
19-02-08 F-1/A Registration statement for certain foreign private issuers [Amend] PDF
19-02-07 F-1/A Registration statement for certain foreign private issuers [Amend] PDF
19-01-30 F-1/A Registration statement for certain foreign private issuers [Amend] PDF
19-01-07 F-1 Registration statement for certain foreign private issuers PDF